Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT.
Author
Hernández-Boluda, Juan-CarlosPereira, Arturo
Zinger, Nienke
Gras, Luuk
Martino, Rodrigo
Nikolousis, Emmanouil
Finke, Jürgen
Chinea, Anabelle
Rambaldi, Alessandro
Robin, Marie
Saccardi, Riccardo
Natale, Annalisa
Snowden, John A
Tsirigotis, Panagiotis
Vallejo, Carlos
Wulf, Gerald
Xicoy, Blanca
Russo, Domenico
Maertens, Johan
Daguindau, Etienne
Lenhoff, Stig
Hayden, Patrick
Czerw, Tomasz
McLornan, Donal P
Yakoub-Agha, Ibrahim
Publication date
2022-06Subject
Oncology. Pathology.
Metadata
Show full item recordAbstract
No abstract availableCitation
Hernández-Boluda JC, Pereira A, Zinger N, Gras L, Martino R, Nikolousis E, Finke J, Chinea A, Rambaldi A, Robin M, Saccardi R, Natale A, Snowden JA, Tsirigotis P, Vallejo C, Wulf G, Xicoy B, Russo D, Maertens J, Daguindau E, Lenhoff S, Hayden P, Czerw T, McLornan DP, Yakoub-Agha I. Correction: Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplant. 2022 Jun;57(6):1051. doi: 10.1038/s41409-022-01652-3. Erratum for: Bone Marrow Transplant. 2022 Mar;57(3):416-422. doi: 10.1038/s41409-021-01553-xType
CorrigendumAdditional Links
http://www.nature.com/bmt/PMID
35361897Journal
Bone Marrow TransplantationPublisher
Nature Publishing Groupae974a485f413a2113503eed53cd6c53
10.1038/s41409-022-01652-3